INHIBITION OF NEURAL ATP RELEASE BY ATRIAL-NATRIURETIC-PEPTIDE IN GUINEA-PIG VAS-DEFERENS

Citation
B. Driessen et J. Goncalves, INHIBITION OF NEURAL ATP RELEASE BY ATRIAL-NATRIURETIC-PEPTIDE IN GUINEA-PIG VAS-DEFERENS, European journal of pharmacology, 296(3), 1996, pp. 261-265
Citations number
14
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
00142999
Volume
296
Issue
3
Year of publication
1996
Pages
261 - 265
Database
ISI
SICI code
0014-2999(1996)296:3<261:IONARB>2.0.ZU;2-L
Abstract
Effects of atrial natriuretic peptide (ANP) and 8-bromoguanosine 3':5' -cyclic monophosphate (8-BrcGMP) on contraction, overflow of tritium ( after [H-3]noradrenaline labelling) and overflow of ATP elicited by el ectrical field stimulation (210 pulses/7 Hz) were studied in guinea-pi g vas deferens. ANP (1-100 nM) slightly increased contractions, did no t alter the overflow of tritium but decreased the overflow of ATP by u p to 50%. 8-BrcGMP (3-300 mu M) markedly reduced contractions and ATP overflow with no effect on tritium overflow. Contractions were suppres sed in the presence of prazosin plus suramin, and evoked overflow of A TP declined to 11%. ANP now gradually increased tritium overflow but a gain decreased the overflow of ATP. 8-BrcGMP did not change tritium ov erflow, as before, but increased ATP overflow. The results indicate th at ANP inhibits neural release of ATP by a mechanism independent of gu anylyl cyclase activation with no major effect on noradrenaline releas e.